Study actively recruiting
Are you pregnant and diagnosed with migraine? Have you taken Nurtec® ODT (rimegepant) or other migraine medications during your pregnancy?
Migraine can be a debilitating condition. Help future pregnant women, doctors, and researchers understand the safety of medications that can provide some relief.
Are you a healthcare provider who treats pregnant women with migraine?
Help us learn more about the safety of using Nurtec® ODT (rimegpant) and other migraine medications during pregnancy.
A pregnancy registry is a study that collects health information from women who take prescription medicines when they are pregnant. Information is also collected on the newborn baby. This information is compared with women who have not taken medicine during pregnancy.
The goal of the MONITOR Pregnancy Registry is to help doctors, patients, and researchers better understand the safety of Nurtec® ODT (rimegepant) and other migraine medications used during pregnancy. Pregnant women in the United States with migraine may be eligible to participate. The study collects health information from enrolled pregnant women and their healthcare providers related to their pregnancies and developing babies up to 1 year of age.